CALCIVIS is in late stage preparation for commercialisation with a “first for dentistry” UK home market launch in 2017. Launch plans are well underway and will include an in-house sales and marketing capability. The CALCIVIS imaging system will be marketed under a CE Mark first announced in February 2014.
Since then a first clinical study has been completed. Additional clinical studies are underway including one specifically designed to support regulatory approval in USA.
CALCIVIS is forming relationships with leading clinicians and dental companies with commercial strength in specific international markets in order to maximise its commercial reach.